Barr makes new try for FDA approval of Plan B OTC sales

Barr Pharmaceuticals is making a second attempt at getting the FDA to approve its morning-after Plan B contraceptive drug for over-the-counter sales by limiting such sales to women at least 16 years old. The plan submitted to the agency is an attempt to overturn the agency's May ruling against OTC sales of Plan B.

View Full Article in:

Newsday (Long Island, N.Y.) (subscription required)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA